Bringing the fundamentals into focus…
Back to Genmab A/S
How Genmab A/S stacks up
GMAB · against 588 other Healthcare companies listed in US-listed
Valuation
51/ 100
Above the middle of the pack.
Ranked #178 of 589 · scores higher than 69% of peers
Bars: peers in each 10-point band of the valuation score57 peers with a valuation score of 50–59, including GMAB · Click a bar to see the companies
Why valuation scores 51?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- EBITDA yield is close to the peer norm. EBITDA yield: 3.7% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 2.3% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 64% of peers. Free cash flow yield: 2.5% vs peer median 0.0%
Metric by metric
Position: dot = GMAB, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | GMAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 2.3% | -4.3% | 74% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 3.7% | -0.8% | 64% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 2.5% | -2.3% | 68% | 20% | |
| Book yieldHigher is better · 587 reported | 18.0% | 25.9% | 38% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around GMAB| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 173 | 10.0B USD | 52 | 43 | |
| 173 | 1.4B USD | 52 | 53 | |
| 173 | 374M USD | 52 | 66 | |
| 173 | 21.7B USD | 52 | 32 | |
| 178 | 34.6B USD | 51 | 58 | |
| 178 | 18.5B USD | 51 | 62 | |
| 178 | 34.0B USD | 51 | 49 | |
| 178 | 11.9B USD | 51 | 53 | |
| 178 | 4.0B USD | 51 | 72 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score